DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 204 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $373,000 | +45.7% | 10,000 | 0.0% | 0.22% | +46.7% |
| Q1 2021 | $256,000 | +16.4% | 10,000 | 0.0% | 0.15% | +19.7% |
| Q4 2020 | $220,000 | -38.9% | 10,000 | -50.0% | 0.13% | +5.8% |
| Q3 2020 | $360,000 | +41.7% | 20,000 | +100.0% | 0.12% | -22.1% |
| Q2 2020 | $254,000 | +38.0% | 10,000 | 0.0% | 0.15% | -5.5% |
| Q1 2020 | $184,000 | -16.4% | 10,000 | 0.0% | 0.16% | +1.9% |
| Q4 2019 | $220,000 | -61.7% | 10,000 | -75.0% | 0.16% | -58.1% |
| Q3 2019 | $574,000 | -19.0% | 40,000 | -11.1% | 0.38% | -11.4% |
| Q2 2019 | $709,000 | +7.6% | 45,000 | 0.0% | 0.43% | +4.4% |
| Q1 2019 | $659,000 | +37.0% | 45,000 | 0.0% | 0.41% | -9.2% |
| Q4 2018 | $481,000 | -30.0% | 45,000 | 0.0% | 0.46% | +2.7% |
| Q3 2018 | $687,000 | +24.7% | 45,000 | 0.0% | 0.44% | +18.4% |
| Q2 2018 | $551,000 | +28.1% | 45,000 | 0.0% | 0.37% | +32.2% |
| Q1 2018 | $430,000 | +5.9% | 45,000 | 0.0% | 0.28% | +18.9% |
| Q4 2017 | $406,000 | +56.8% | 45,000 | 0.0% | 0.24% | +77.6% |
| Q3 2017 | $259,000 | +311.1% | 45,000 | +125.0% | 0.13% | +306.1% |
| Q2 2017 | $63,000 | – | 20,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|